FDA Inspection
Blood Bank of Delmarva, a Division of New York Blood Center, Inc.Blood Bank of Delmarva, a Division of New York Blood Center, Inc. – FDA Inspection, Dec 19, 2019
Record Details
This FDA Inspection record concerns Blood Bank of Delmarva, a Division of New York Blood Center, Inc., with an inspection on December 19, 2019, issued by the Center for Biologics Evaluation and Research, covering biologics.
- Inspection Date
- December 19, 2019
- Product Type
- Biologics
View Company Profile
ID · 78958acf-08e9-45b2-aaed-6b1205961424
Inspection Facts
No Action Indicated (NAI)
No objectionable conditions or practices were found during the inspection.
- Inspection number
- 1118760
- FDA center
- Biologics
- Project area
- Blood and Blood Products
Other FDA inspections of Blood Bank of Delmarva, a Division of New York Blood Center, Inc.
3| Date | Classification | Office | Project area |
|---|---|---|---|
| July 25, 2024 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| November 7, 2017 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| November 19, 2015 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
Other documents for Blood Bank of Delmarva, a Division of New York Blood Center, Inc.
- FDA Inspection 1246985 - 2024-07-25
- FDA Inspection 1034939 - 2017-11-07
- FDA Inspection 952722 - 2015-11-19
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.